Cytokine imbalance after measles virus infection has no correlation with immune suppression

Journal of Virology

Volumn 83, Issue 14, 2009, Pages 7244-7251

  Carsillo, Mary ^a   Klapproth, Kay ^b   Niewiesk, Stefan ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Department of Veterinary Biosciences ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; IONOMYCIN; KEYHOLE LIMPET HEMOCYANIN; MEASLES VACCINE; PHORBOL 13 ACETATE 12 MYRISTATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORRELATION ANALYSIS; CYTOKINE RELEASE; IMMUNE DEFICIENCY; INBRED STRAIN; LUNG LAVAGE; MACROPHAGE; MEASLES; MEASLES VIRUS; MEDIASTINUM LYMPH NODE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SPLEEN CELL; TH2 CELL; VIRUS RECOMBINANT;

ANIMALS; CELLS, CULTURED; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-12; INTERLEUKIN-4; MACROPHAGES; MEASLES; MEASLES VIRUS; MICE; MICE, INBRED C3H; RATS; RATS, INBRED STRAINS; SPECIFIC PATHOGEN-FREE ORGANISMS; TH1 CELLS; TH2 CELLS;

MEASLES VIRUS; SIGMODON;

EID: 67650450508     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00148-09     Document Type: Article

References (43)

1. Atabani, S. F., A. A. Byrnes, A. Jaye, I. M. Kidd, A. F. Magnusen, H. Whittle, and C. L. Karp. 2001. Natural measles causes prolonged suppression of interleukin-12 production. J. Infect. Dis. 184:1-9.
2. Blanco, J. C., L. Pletneva, M. Boukhvalova, J. Y. Richardson, K. A. Harris, and G. Prince. 2004. The cotton rat: an underutilized animal model for human infectious diseases can now be exploited using specific reagents to cytokines, chemokines, and interferons. J. Interferon Cytokine Res. 24: 21-28.
3. Caparros, E., P. Munoz, E. Sierra-Filardi, D. Serrano-Gomez, A. Puig-Kroger, J. L. Rodriguez-Fernandez, M. Mellado, J. Sancho, M. Zubiaur, and A. L. Corbi. 2006. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 107:3950-3958.
4. Carsillo, M., V. K. Kutala, K. Puschel, J. Blanco, P. Kuppusamy, and S. Niewiesk. 2009. Nitric oxide production and nitric oxide synthase type 2 expression by cotton rat (Sigmodon hispidus) macrophages reflect the same pattern as human macrophages. Dev. Comp. Immunol. 33:718-724.
5. Carsillo, T., M. Carsillo, S. Niewiesk, D. Vasconcelos, and M. J. Oglesbee. 2004. Hyperthermic pre-conditioning promotes measles virus clearance from brain in a mouse model of persistent infection. Brain Res. 1004:73-82.
6. de Witte, L., M. Abt, S. Schneider-Schaulies, Y. van Kooyk, and T. B. Geijtenbeek. 2006. Measles virus targets DC-SIGN to enhance dendritic cell infection. J. Virol. 80:3477-3486.
7. Dhiman, N., I. G. Ovsyannikova, R. C. Howe, J. E. Ryan, R. M. Jacobson, and G. A. Poland. 2004. Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA. J. Immunol. Methods 287:217-225.
8. Esolen, M. E., S. W. Park, J. M. Hardwick, and D. E. Griffin. 1995. Apoptosis as a cause of death in measles virus-infected cells. J. Virol. 69:3955-3958.
9. Fontana, J. M., B. Bankamp, and P. A. Rota. 2008. Inhibition of interferon induction and signaling by paramyxoviruses. Immunol. Rev. 225:46-67.
10. Fujinami, R. S., X. Sun, J. M. Howell, J. C. Jenkin, and J. B. Burns. 1998. Modulation of immune system function by measles virus infection: role of soluble factor and direct infection. J. Virol. 72:9421-9427.
11. Gans, H. A., Y. Maldonado, L. L. Yasukawa, J. Beeler, S. Audet, M. M. Rinki, R. DeHovitz, and A. M. Arvin. 1999. IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. J. Immunol. 162:5569-5575.
12. Griffin, D. E., J. B. Ward, et al. 1990. Immune activation during measles: interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J. Infect. Dis. 161:449-453.
13. Gringhuis, S. I., J. den Dunnen, M. Litjens, B. van Het Hof, Y. van Kooyk, and T. B. Geijtenbeek. 2007. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 26:605-616.
14. Hahm, B., J. H. Cho, and M. B. Oldstone. 2007. Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis. Virology 358:251-257.
15. Hoffman, S. J., F. P. Polack, D. A. Hauer, M. Singh, M. A. Billeter, R. J. Adams, and D. E. Griffin. 2003. Vaccination of rhesus macaques with a recombinant measles virus expressing interleukin-12 alters humoral and cellular immune responses. J. Infect. Dis. 188:1553-1563.
16. Howe, R. C., I. G. Ovsyannikova, N. A. Pinsky, and G. A. Poland. 2005. Identification of Th0 cells responding to measles virus. Hum. Immunol. 66:104-115.
17. Jackson, R. J., A. J. Ramsay, C. D. Christensen, S. Beaton, D. F. Hall, and I. A. Ramshaw. 2001. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J. Virol. 75:1205-1210.
18. Karp, C. L., M. Wysocka, L. M. Wahl, J. M. Ahearn, P. J. Cuomo, B. Sherry, G. Trinchieri, and D. E. Griffin. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228-231.
19. Klagge, I. M., M. Abt, B. Fries, and S. Schneider-Schaulies. 2004. Impact of measles virus dendritic-cell infection on Th-cell polarization in vitro. J. Gen. Virol. 85:3239-3247.
20. Kovacs, G. R., C. L. Parks, N. Vasilakis, and S. A. Udem. 2003. Enhanced genetic rescue of negative-strand RNA viruses: use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors. J. Virol. Methods 111: 29-36.
21. Li, H., C. J. Hickman, R. F. Helfand, H. Keyserling, L. J. Anderson, and W. J. Bellini. 2001. Induction of cytokine mRNA in peripheral blood mononuclear cells of infants after the first dose of measles vaccine. Vaccine 19:4896-4900.
22. Moss, W. J., J. J. Ryon, M. Monze, and D. E. Griffin. 2002. Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children. J. Infect. Dis. 186:879-887.
23. Niewiesk, S., I. Eisenhuth, A. Fooks, J. C. S. Clegg, J.-J. Schnorr, S. Schneider-Schaulies, and V. ter Meulen. 1997. Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins. J. Virol. 71:7214-7219.
24. Noelle, R., P. H. Krammer, J. Ohara, J. W. Uhr, and E. S. Vitetta. 1984. Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. Proc. Natl. Acad. Sci. USA 81:6149-6153.
25. O'Garra, A., D. J. Warren, M. Holman, A. M. Popham, C. J. Sanderson, and G. G. Klaus. 1986. Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes. Proc. Natl. Acad. Sci. USA 83:5228-5232.
26. Ohno, S., N. Ono, M. Takeda, K. Takeuchi, and Y. Yanagi. 2004. Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J. Gen. Virol. 85:2991-2999.
27. Ono, N., H. Tatsuo, Y. Hidaka, T. Aoki, H. Minagawa, and Y. Yanagi. 2001. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J. Virol. 75:4399-4401.
28. Ovsyannikova, I. G., J. E. Ryan, R. A. Vierkant, V. S. Pankratz, R. M. Jacobson, and G. A. Poland. 2005. Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses. Immunogenetics 57:828-836.
29. Pasetti, M. F., K. Ramirez, A. Resendiz-Albor, J. Ulmer, E. M. Barry, and M. M. Levine. 2009. Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity. J. Virol. 83:2789-2794.
30. Pfeuffer, J., K. Püschel, V. ter Meulen, J. Schneider-Schaulies, and S. Niewiesk. 2003. Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus). J. Virol. 77:150-158.
31. Polack, F. P., S. J. Hoffman, W. J. Moss, and D. E. Griffin. 2002. Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles. J. Infect. Dis. 185:13-19.
32. Pueschel, K., A. Tietz, M. Carsillo, M. Steward, and S. Niewiesk. 2007. Measles virus-specific CD4 T-cell activity does not correlate with protection against lung infection or viral clearance. J. Virol. 81:8571-8578.
33. Radecke, F., P. Spielhofer, H. Schneider, K. Kaelin, M. Huber, C. Dötsch, G. Christiansen, and M. A. Billeter. 1995. Rescue of measles virus from cloned DNA. EMBO J. 14:5773-5784.
34. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hygiene 27:493-497.
35. Schlender, J., J. J. Schnorr, T. Cattomen, R. Cattaneo, M. A. Billeter, V. ter Meulen, and S. Schneider-Schaulies. 1996. Surface interaction of measles virus glycoproteins is necessary and sufficient for the induction of proliferative inhibition of human peripheral blood mononuclear cells. Proc. Natl. Acad. Sci. USA 93:13194-13199.
36. Schneider-Schaulies, J., and S. Schneider-Schaulies. 2008. Receptor interactions, tropism, and mechanisms involved in morbillivirus-induced immunomodulation. Adv. Virus Res. 71:173-205.
37. Schnorr, J. J., F. T. Cutts, J. G. Wheeler, S. M. Akramuzzaman, M. S. Alam, T. Azim, S. Schneider-Schaulies, and V. ter Meulen. 2001. Immune modulation after measles vaccination of 6-9 months old Bangladeshi infants. Vaccine 19:1503-1510.
38. Singh, M., and M. A. Billeter. 1999. A recombinant measles virus expressing biologically active human interleukin-12. J. Gen. Virol. 80:101-106.
39. Sun, X., J. B. Burns, J. M. Howell, and R. S. Fujinami. 1998. Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression. Virology 246:24-33.
40. Wang, M., J. E. Libbey, I. Tsunoda, and R. S. Fujinami. 2003. Modulation of immune system function by measles virus infection. II. Infection of B cells leads to the production of a soluble factor that arrests uninfected B cells in G0/G1. Vir. Immunol. 16:45-55.
41. Ward, B. J., and D. E. Griffin. 1993. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin. Immunol. Immunopathol. 67:171-177.
42. Ward, B. J., R. T. Johnson, A. Vaisberg, E. Jauregui, and D. E. Griffin. 1991. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin. Immunol. Immunopathol. 61:236-248.
43. Yokota, S., T. Okabayashi, N. Yokosawa, and N. Fujii. 2008. Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20. FASEB J. 22:74-83.